BioSpace News Archive

Deals

Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering

Exicure, Inc. announced today it expects to close a private placement offering of its common stock at a per share price of $4.50 and aggregate gross proceeds of approximately $22 million before fees and expenses.

August 22, 2018
·
4 min read
Policy

StratEdge Receives ISO 9001:2015 Quality Management Systems Certification

StratEdge Corporation announces that DNV GL – Business Assurance has found StratEdge Corporation to conform to the Quality Management System standard ISO 9001:2015.

August 22, 2018
·
2 min read
Business

Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO

Calyxt to host conference call on Wednesday, August 22, 2018 at 8:30 a.m. ET – 7:30 a.m. CT

August 22, 2018
·
5 min read
Business

Sound Affects/Vevo Partnership Advances the War on Cancer

Sound Affects announces strategic partnership with Vevo, the world’s leading music video and entertainment platform.

August 22, 2018
·
2 min read
Lone Star Bio

Parks Associates: 17% of U.S. Broadband Households Interested in Purchasing an Independent Living System

Parks Associates’ pre-conference workshop to focus on independent living and wellness

August 22, 2018
·
3 min read
Business

Russell Brand to Headline Wanderlust’s First Annual Wellspring

Presenting the program that saved his life, actor, comedian and bestselling author Russell Brand will share his personal journey of recovery along with practical advice for living in the Age of Addiction

August 22, 2018
·
7 min read
Genetown

Montgomery General Hospital Signs for MEDITECH Expanse with Subscription-Based MaaS Model

MEDITECH’s Software as a Service model will reduce the complexity of procuring, deploying and managing a modern EHR at Montgomery General Hospital

August 22, 2018
·
3 min read
Business

MDVIP Certified as Great Place to Work®

Employees at National Primary Care Network Praise the Company’s Atmosphere, Communication and Leadership

August 22, 2018
·
3 min read
Drug Development

AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids

Study results (ELARIS UF-EXTEND) showed elagolix, in combination with add-back therapy, reduced heavy menstrual bleeding for up to 12 months

August 22, 2018
·
13 min read
Biotech Beach

Halozyme Therapeutics To Participate In Upcoming Investor Conferences this September 2018

Halozyme Therapeutics, Inc. will participate in two upcoming investor conferences.

August 22, 2018
·
1 min read